Defining response to anti-VEGF therapies in neovascular AMD-Reference-Cited by-同舟云学术

Defining response to anti-VEGF therapies in neovascular AMD

Published:2015-04-17 Issue:6 Volume:29 Page:721-731
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Amoaku W M,Chakravarthy U,Gale R,Gavin M,Ghanchi F^ORCID,Gibson J,Harding S,Johnston R L,Kelly S,Lotery A^ORCID,Mahmood S,Menon G,Sivaprasad S,Talks J,Tufail A,Yang Y

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye201548.pdf

Reference77 articles.

1. Bloch SB, Larsen M, Munch IC . Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol 2012; 153: 209–213.

2. Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O . Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol 2012; 153: 214–221.

3. Rostron E, McKibbin M . Visual impairment certification secondary to ARMD in Leeds, 2005–2010: is the incidence falling? Eye (Lond) 2012; 26: 933–936.

4. Keenan TD, Kelly SP, Sallam A, Mohamed Q, Tufail A, Johnston RL et al. Incidence and baseline clinical characteristics of treated neovascular age-related macular degeneration in a well-defined region of the UK. Br J Ophthalmol 2013; 97: 1168–1172.

5. Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K SEVEN-UP Study Group.. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 2013; 120: 2292–2299.

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glaucine inhibits hypoxia-induced angiogenesis and attenuates LPS-induced inflammation in human retinal pigment epithelial ARPE-19 cells;European Journal of Pharmacology;2024-10

2. Short-term results with faricimab in neovascular age-related macular degeneration resistant to both ranibizumab and aflibercept;AJO International;2024-10

3. Predictors of Disease Activity After Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration Using Real-World Data from the PROOF Study;Ophthalmology and Therapy;2024-09-05

4. Identification of highly potent and selective HTRA1 inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-09

5. Visual and Anatomic Responses in Patients With Neovascular Age-Related Macular Degeneration and a Suboptimal Response to Anti-VEGF Therapy Switched to Faricimab;Journal of VitreoRetinal Diseases;2024-08-31